References
- Cao MJ, Osatomi K, Matsuda R, et al (2000). Purification of a novel serine proteinase inhibitor from the skeletal muscle of white croaker (Argyrosomus argentatus). Biochem Biophys Res Commun, 272, 485-89. https://doi.org/10.1006/bbrc.2000.2803
- Cheng CC, Yang SM, Huang CY, et al (2005). Molecular mechanisms of ginsenoside Rh2-mediated G1 growth arrest and apoptosis in human lung adenocarcinoma A549 cells. Cancer Chemother Pharmacol, 55, 531-40. https://doi.org/10.1007/s00280-004-0919-6
- Christensen, LP (2009). Ginsenosides chemistry, biosynthesis, analysis, and potential health effects. Adv Food Nutrition Res, 55, 1-99.
- Chung KS, Cho SH, Shin JS, et al (2013). Ginsenoside Rh2 induces cell cycle arrest and differentiation in human leukemia cells by upregulating TGF-beta expression. Carcinogenesis, 34, 331-40. https://doi.org/10.1093/carcin/bgs341
- Dennis PB, Jaeschke A, Saitoh M, et al (2001). Mammalian TOR: a homeostatic ATP sensor. Science, 294, 1102-5. https://doi.org/10.1126/science.1063518
- Fu M, Li L, Albrecht T, et al (2011). Autocrine motility factor/phosphoglucose isomerase regulates ER stress and cell death through control of ER calcium release. Cell Death Differ, 18, 1057-70. https://doi.org/10.1038/cdd.2010.181
- Funasaka T, Hogan V, Raz A (2009). Phosphoglucose isomerase/autocrine motility factor mediates epithelial and mesenchymal phenotype conversions in breast cancer. Cancer Res, 69, 5349-56. https://doi.org/10.1158/0008-5472.CAN-09-0488
- Funasaka T, Hu H, Hogan V, et al (2007). Down-regulation of phosphoglucose isomerase/autocrine motility factor expression sensitizes human fibrosarcoma cells to oxidative stress leading to cellular senescence. Journal Chem, 282, 36362-9.
- Funasaka T, Hu H, Yanagawa T, et al (2007). Down-regulation of phosphoglucose isomerase/autocrine motility factor results in mesenchymal-to-epithelial transition of human lung fibrosarcoma cells. Cancer Res, 67, 4236-43. https://doi.org/10.1158/0008-5472.CAN-06-3935
- Gingras AC, Raught B, Sonenberg N (2001). Regulation of translation initiation by FRAP/mTOR. Genes Dev, 15, 807-26. https://doi.org/10.1101/gad.887201
- Guarino M (2007). Epithelial-mesenchymal transition and tumour invasion. Int J Biochem Cell bio, 39, 2153-60. https://doi.org/10.1016/j.biocel.2007.07.011
- Gwinn DM, Shackelford DB, Egan DF, et al (2008). AMPK phosphorylation of raptor mediates a metabolic checkpoint. Mol Cell, 30, 214-26. https://doi.org/10.1016/j.molcel.2008.03.003
- Haga A, Funasaka T, Niinaka Y, et al (2003). Autocrine motility factor signaling induces tumor apoptotic resistance by regulations Apaf-1 and Caspase-9 apoptosome expression. International journal of cancer. Int J Cancer, 107, 707-14. https://doi.org/10.1002/ijc.11449
- Helms S (2004). Cancer prevention and therapeutics: Panax ginseng. Alter Med Rev, 9, 259-74.
- Huang S, Houghton PJ (2003). Targeting mTOR signaling for cancer therapy. Cur Opin Pharmacol, 3, 371-7. https://doi.org/10.1016/S1471-4892(03)00071-7
- Kho DH, Nangia-Makker P, Balan V, et al (2013). Autocrine motility factor promotes HER2 cleavage and signaling in breast cancer cells. Cancer Res, 73, 1411-9. https://doi.org/10.1158/0008-5472.CAN-12-2149
- Kovacina KS, Park GY, Bae SS, et al (2003). Identification of a proline-rich Akt substrate as a 14-3-3 binding partner. J Biol Chem, 278, 10189-94. https://doi.org/10.1074/jbc.M210837200
- Lee JM, Dedhar S, Kalluri R, et al (2006). The epithelial-mesenchymal transition: new insights in signaling, development, and disease. J Cell Biol, 172, 973-81. https://doi.org/10.1083/jcb.200601018
- Li B, Zhao J, Wang CZ, et al (2011). Ginsenoside Rh2 induces apoptosis and paraptosis-like cell death in colorectal cancer cells through activation of p53. Cancer lett, 301, 185-92. https://doi.org/10.1016/j.canlet.2010.11.015
- Matsumoto I, Staub A, Benoist C, et al (1999). Arthritis provoked by linked T and B cell recognition of a glycolytic enzyme. Science, 286, 1732-5. https://doi.org/10.1126/science.286.5445.1732
- Nicholson KM, Anderson NG (2002). The protein kinase B/Akt signalling pathway in human malignancy. Cell Signal, 14, 381-95. https://doi.org/10.1016/S0898-6568(01)00271-6
- Niinaka Y, Harada K, Fujimuro M, et al (2010). Silencing of autocrine motility factor induces mesenchymal-to-epithelial transition and suppression of osteosarcoma pulmonary metastasis. Cancer Res, 70, 9483-93. https://doi.org/10.1158/0008-5472.CAN-09-3880
- Park EK, Lee EJ, Lee SH, et al (2010). Induction of apoptosis by the ginsenoside Rh2 by internalization of lipid rafts and caveolae and inactivation of Akt. Br J Pharmacol, 160, 1212-23. https://doi.org/10.1111/j.1476-5381.2010.00768.x
- Park HM, Kim SJ, Kim JS, et al (2012). Reactive oxygen species mediated ginsenoside Rg3- and Rh2-induced apoptosis in hepatoma cells through mitochondrial signaling pathways. Food Chem Toxicol, 50, 2736-41. https://doi.org/10.1016/j.fct.2012.05.027
- Sancak Y, Thoreen CC, Peterson TR, et al, (2007). PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase. Mol Cell, 25, 903-15. https://doi.org/10.1016/j.molcel.2007.03.003
- Shih WL, Yu FL, Chang CD, et al (2012). Suppression of AMF/PGI-mediated tumorigenic activities by ursolic acid in cultured hepatoma cells and in a mouse model. Mol Carcinog, 52, 800-12
- Tang XP, Tang GD, Fang CY, et al (2013). Effects of ginsenoside Rh2 on growth and migration of pancreatic cancer cells. World J Gastroenterol, 19, 1582-92. https://doi.org/10.3748/wjg.v19.i10.1582
- Thiery JP, Sleeman JP (2006). Complex networks orchestrate epithelial-mesenchymal transitions. Nat Rev Mol Cell Biol, 7, 131-42. https://doi.org/10.1038/nrm1835
- Tsutsumi S, Hogan V, Nabi IR, et al (2003). Overexpression of the autocrine motility factor/phosphoglucose isomerase induces transformation and survival of NIH-3T3 fibroblasts. Cancer Res, 63, 242-9.
- Tsutsumi S, Yanagawa T, Shimura T, et al (2003). Regulation of cell proliferation by autocrine motility factor/phosphoglucose isomerase signaling. J Biol Chem, 278, 32165-72. https://doi.org/10.1074/jbc.M304537200
- Vander Haar E, Lee SI, Bandhakavi S, et al (2007). Insulin signalling to mTOR mediated by the Akt/PKB substrate PRAS40. Nat Cell Biol, 9, 316-23. https://doi.org/10.1038/ncb1547
- Wang W, Wang H, Rayburn ER, et al (2008). 20 (S)-25-methoxyl-dammarane-3beta, 12beta, 20-triol, a novel natural product for prostate cancer therapy: activity in vitro and in vivo and mechanisms of action. Br J Cancer, 98, 792-802. https://doi.org/10.1038/sj.bjc.6604227
- Wang Z, Zheng Q, Liu K, et al (2006). Ginsenoside Rh (2) enhances antitumour activity and decreases genotoxic effect of cyclophosphamide. Basic Clin Pharmacol Toxicol, 98, 411-5. https://doi.org/10.1111/j.1742-7843.2006.pto_348.x
- Wullschleger S, Loewith R, Hall MN (2006). TOR signaling in growth and metabolism. Cell, 124, 471-84. https://doi.org/10.1016/j.cell.2006.01.016
- Xu W, Seiter K, Feldman E, et al (1996). The differentiation and maturation mediator for human myeloid leukemia cells shares homology with neuroleukin or phosphoglucose isomerase. Blood, 87, 4502-6.
- Yakirevich E, Naot Y (2000). Cloning of a glucose phosphate isomerase/neuroleukin-like sperm antigen involved in sperm agglutination. Biol Reprod, 62, 1016-23. https://doi.org/10.1095/biolreprod62.4.1016
- Yanagawa T, Funasaka T, Tsutsumi S, et al (2004). Novel roles of the autocrine motility factor/phosphoglucose isomerase in tumor malignancy. Endocr Relat Cancer, 11, 749-59. https://doi.org/10.1677/erc.1.00811
- Zhang C, Yu H, Hou J (2011). Effects of 20 (S) -ginsenoside Rh2 and 20 (R) -ginsenoside Rh2 on proliferation and apoptosis of human lung adenocarcinoma A549 cells. Zhongguo Zhong Yao Za Zhi, 36, 1670-4.
Cited by
- Proliferative and Inhibitory Activity of Siberian ginseng (Eleutherococcus senticosus) Extract on Cancer Cell Lines; A-549, XWLC-05, HCT-116, CNE and Beas-2b vol.16, pp.11, 2015, https://doi.org/10.7314/APJCP.2015.16.11.4781
- How do glycolytic enzymes favour cancer cell proliferation by nonmetabolic functions? vol.34, pp.29, 2015, https://doi.org/10.1038/onc.2014.320
- 20(S)-Ginsenoside Rh2 Induce the Apoptosis and Autophagy in U937 and K562 Cells vol.10, pp.3, 2018, https://doi.org/10.3390/nu10030328